These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17925193)

  • 1. Cancer-associated bone disease.
    Brown SA; Guise TA
    Curr Osteoporos Rep; 2007 Sep; 5(3):120-7. PubMed ID: 17925193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer therapies and bone health.
    Hu MI; Lu H; Gagel RF
    Curr Rheumatol Rep; 2010 Jun; 12(3):177-85. PubMed ID: 20437119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss.
    Dionísio MR; Mansinho A; Abreu C; Cavaco-Silva J; Casimiro S; Costa L
    Br J Clin Pharmacol; 2019 Jun; 85(6):1114-1124. PubMed ID: 30601585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone health in the elderly cancer patient: A SIOG position paper.
    Body JJ; Terpos E; Tombal B; Hadji P; Arif A; Young A; Aapro M; Coleman R
    Cancer Treat Rev; 2016 Dec; 51():46-53. PubMed ID: 27863287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bisphosphonates in breast and prostate cancers.
    Brown JE; Neville-Webbe H; Coleman RE
    Endocr Relat Cancer; 2004 Jun; 11(2):207-24. PubMed ID: 15163299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The skeletal impact of cancer therapies.
    Bedatsova L; Drake MT
    Br J Clin Pharmacol; 2019 Jun; 85(6):1161-1168. PubMed ID: 30723928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local effects of malignancy on bone.
    Brown SA; Clines GA; Guise TA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates' use in metastatic bone disease.
    Hubner RA; Houston SJ
    Hosp Med; 2005 Jul; 66(7):414-9. PubMed ID: 16025799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in the prevention and treatment of bone metastases.
    Ramaswamy B; Shapiro CL
    Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease.
    Coleman RE; Purohit OP; Black C; Vinholes JJ; Schlosser K; Huss H; Quinn KJ; Kanis J
    Ann Oncol; 1999 Mar; 10(3):311-6. PubMed ID: 10355575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
    McKeage K; Plosker GL
    Pharmacoeconomics; 2008; 26(3):251-68. PubMed ID: 18282018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing cancer-related skeletal events with bisphosphonates.
    Rule S
    Hosp Med; 2004 Jun; 65(6):355-60. PubMed ID: 15222212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic bone disease and the role of bisphosphonates.
    Ellis MJ
    Br J Hosp Med; 1996 Oct 2-15; 56(7):339-45. PubMed ID: 8899222
    [No Abstract]   [Full Text] [Related]  

  • 15. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal complications of malignancy.
    Coleman RE
    Cancer; 1997 Oct; 80(8 Suppl):1588-94. PubMed ID: 9362426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates and bone metastases].
    Lortholary A; Jadaud E; Berthaud P
    Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.
    Harvey HA; Lipton A
    Support Care Cancer; 1996 May; 4(3):213-7. PubMed ID: 8739655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of bisphosphonates in treating bone metastases.
    Merlini G; Turesson I
    Med Oncol; 1996 Dec; 13(4):215-21. PubMed ID: 9152972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.